A Molecular Signature Predictive of Indolent Prostate Cancer-Reference-Cited by-同舟云学术

A Molecular Signature Predictive of Indolent Prostate Cancer

Published:2013-09-11 Issue:202 Volume:5 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Irshad Shazia¹,Bansal Mukesh²,Castillo-Martin Mireia³,Zheng Tian⁴⁵,Aytes Alvaro¹,Wenske Sven¹⁴,Le Magnen Clémentine¹,Guarnieri Paolo²⁴,Sumazin Pavel²,Benson Mitchell C.¹⁴,Shen Michael M.²⁴⁶⁷,Califano Andrea²⁴⁸⁹¹⁰,Abate-Shen Cory¹²⁴¹¹

Affiliation:

1. Department of Urology, Columbia University Medical Center, New York, NY 10029, USA.

2. Department of Systems Biology, Columbia University Medical Center, New York, NY 10029, USA.

3. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

4. Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA.

5. Department of Statistics, Columbia University, New York, NY 10027, USA.

6. Department of Medicine, Columbia University Medical Center, New York, NY 10029, USA.

7. Department of Genetics and Development, Columbia University Medical Center, New York, NY 10029, USA.

8. Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY 10029, USA.

9. Department of Biomedical Informatics, Columbia University Medical Center, New York, NY 10029, USA.

10. Institute for Cancer Genetics, Columbia University Medical Center, New York, NY 10029, USA.

11. Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10029, USA.

Abstract

A three-gene panel derived from mechanistic models of cell senescence predicts outcome of low Gleason score prostate tumors.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference61 articles.

1. Cancer Statistics, 2010

2. Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment

3. Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005

4. Beyond PSA: The Next Generation of Prostate Cancer Biomarkers

5. Histologic grading of prostate cancer: A perspective

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts;Journal of Clinical Investigation;2024-05-23

2. Parathyroid hormone related-protein (PTHrP) in tissues with poor prognosis in prostate cancer patients;Medicine;2024-04-26

3. Identification of an anaplastic subtype of prostate cancer amenable to therapies targeting SP1 or translation elongation;Science Advances;2024-04-05

4. Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m;International Journal of Molecular Sciences;2024-03-23

5. Elucidating Cancer Subtypes by Using Epigenome and Genome Cross-Talk;Lecture Notes in Computer Science;2024